Profilo
Jayakrishna Ambati is the founder of Inflammasome Therapeutics, Inc. which was founded in 2016, where he holds the title of Director.
He is currently working as Director & VP-Advanced Ocular Design at iVeena Delivery Systems, Inc.
Posizioni attive di Jayakrishna Ambati
| Società | Posizione | Inizio |
|---|---|---|
iVeena Delivery Systems, Inc.
 iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Direttore/Membro del Consiglio | - |
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Fondatore | 01/01/2016 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
iVeena Delivery Systems, Inc.
iVeena Delivery Systems, Inc. Pharmaceuticals: MajorHealth Technology iVeena Delivery Systems, Inc. engages in the manufacture of eye drops. It develops ocular drug products that eliminate the need to apply eye drops and painful injections. The company was founded by Balamurali Ambati and is headquartered in Salt Lake, UT. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Borsa valori
- Insiders
- Jayakrishna Ambati
